Life Science Analytics (LSA)Overview Our Products
Each report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally each report includes quarterly book value per share vs. share price. Much of the information contained in each report is included in both tabular and graphic formats.
Product Pipeline Reports
Competitor Reports
Deals & Alliances Reports
|
List of reports from Life Science Analytics (LSA)
|
Adonis Laboratories Pvt. Ltd.-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview ...
|
more...
|
$750.00
|
|
Noven Pharmaceuticals, Inc.-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and ...
|
more...
|
$750.00
|
|
AGIO PHARMACEUTICALS LTD.-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and ...
|
more...
|
$750.00
|
|
ev3, Inc.-Deals & Alliances Report
1/7/2010 | published by: Life Science Analytics (LSA)
... deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where ...
|
more...
|
$600.00
|
|
Gen-Probe Inc.-Deals & Alliances Report
1/7/2010 | published by: Life Science Analytics (LSA)
... deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where ...
|
more...
|
$600.00
|
|
Alfresa Pharma Corporation-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and ...
|
more...
|
$750.00
|
|
Medarex Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...
|
more...
|
$350.00
|
|
Medarex Inc-Detailed Product Pipeline
1/7/2010 | published by: Life Science Analytics (LSA)
... reports Each Life Science Analytics’ Pipeline Report provides the user with real detail on a company’s pipeline. In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive ...
|
more...
|
$750.00
|
|
H. Lundbeck A/S-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and ...
|
more...
|
$750.00
|
|
Lundbeck Inc. (formerly OVATION Pharmaceuticals, Inc.)-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a ...
|
more...
|
$750.00
|
|
Medarex, Inc.-Deals & Alliances Report
1/7/2010 | published by: Life Science Analytics (LSA)
... deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where ...
|
more...
|
$600.00
|
|
XELR8 Holdings, Inc.-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Kureha Corporation (formerly Kureha Chemical Industry Co., Ltd.)-Company Report
1/7/2010 | published by: Life Science Analytics (LSA)
... reports Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report ...
|
more...
|
$750.00
|
|
Integra LifeSciences Holdings Corp.-Deals & Alliances Report
1/7/2010 | published by: Life Science Analytics (LSA)
... of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner ...
|
more...
|
$600.00
|
|
Aastrom Biosciences, Inc.-Deals & Alliances Report
1/7/2010 | published by: Life Science Analytics (LSA)
... partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm ...
|
more...
|
$600.00
|
|
Advanced Cell Technology Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...
|
more...
|
$350.00
|
|
Altus Pharmaceuticals Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Avigen Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...
|
more...
|
$350.00
|
|
BioForm Medical, Inc.-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Biopath Holdings, Inc.-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Capstone Therapeutics-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...
|
more...
|
$350.00
|
|
Cell Genesys Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Ceragenix Pharmaceuticals Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...
|
more...
|
$350.00
|
|
Chattem Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...
|
more...
|
$350.00
|
|
CombinatoRx Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...
|
more...
|
$350.00
|

